國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 914191      在线人数 : 1315
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版

    类别统计

    近3年内发表的文件:10(55.56%)
    含全文笔数:18(100.00%)

    文件下载次数统计
    下载大于0次:18(100.00%)
    下载大于100次:17(94.44%)
    全文下载总次数:3879(100.00%)

    最后更新时间: 2024-12-01 13:16


    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目1-10 / 18. (共2页)
    1 2 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2024-06-24 Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease European Polymer Journal. 2024 Jun 24;214:Article number 113151.
    2024-05-09 Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function Journal of Biomedical Science. 2024 May 09;31:Article number 46.
    2023-11 Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death Pharmacological Research. 2023 Nov;197:Article number 106945.
    2023-03-28 Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
    2023-02-28 How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
    2023-02-03 MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
    2023-01-19 The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b [Erratum:Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.] Pharmaceutics. 2023 Jan 19;15(2):Article number 342.
    2022-07-21 The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.
    2022-03-16 Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.
    2022-03-02 Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782.

    显示项目1-10 / 18. (共2页)
    1 2 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈